Trial · NCT00041119
Adverse events1,400
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 1,400
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anemia | Blood and lymphatic system disorders | Arm I (CA for 4 Courses) | 0 | 1,110 | 0 |
| other | Anemia | Blood and lymphatic system disorders | Arm II (CA for 6 Courses [Closed to Accrual 12/15/2007]) | 1 | 765 | 1 |
| other | Anemia | Blood and lymphatic system disorders | Arm III (Paclitaxel for 4 Courses) | 1 | 1,118 | 2 |
| other | Anemia | Blood and lymphatic system disorders | Arm IV (Paclitaxel for 6 Courses [Closed 12/15/2007]) | 0 | 762 | 0 |
| other | Febrile neutropenia | Blood and lymphatic system disorders | Arm I (CA for 4 Courses) | 44 | 1,110 | 52 |
| other | Febrile neutropenia | Blood and lymphatic system disorders | Arm II (CA for 6 Courses [Closed to Accrual 12/15/2007]) | 33 | 765 | 41 |
| other | Febrile neutropenia | Blood and lymphatic system disorders | Arm III (Paclitaxel for 4 Courses) | 3 | 1,118 | 3 |
| other | Febrile neutropenia | Blood and lymphatic system disorders | Arm IV (Paclitaxel for 6 Courses [Closed 12/15/2007]) | 1 | 762 | 1 |
| other | Hemoglobin decreased | Blood and lymphatic system disorders | Arm I (CA for 4 Courses) | 698 | 1,110 | 1,742 |
| other | Hemoglobin decreased | Blood and lymphatic system disorders | Arm II (CA for 6 Courses [Closed to Accrual 12/15/2007]) | 519 | 765 | 1,789 |
| other | Hemoglobin decreased | Blood and lymphatic system disorders | Arm III (Paclitaxel for 4 Courses) | 440 | 1,118 | 990 |
| other | Hemoglobin decreased | Blood and lymphatic system disorders | Arm IV (Paclitaxel for 6 Courses [Closed 12/15/2007]) | 337 | 762 | 1,034 |
| other | Hemolysis | Blood and lymphatic system disorders | Arm I (CA for 4 Courses) | 0 | 1,110 | 0 |
| other | Hemolysis | Blood and lymphatic system disorders | Arm II (CA for 6 Courses [Closed to Accrual 12/15/2007]) | 1 | 765 | 1 |
| other | Hemolysis | Blood and lymphatic system disorders | Arm III (Paclitaxel for 4 Courses) | 0 | 1,118 | 0 |
| other | Hemolysis | Blood and lymphatic system disorders | Arm IV (Paclitaxel for 6 Courses [Closed 12/15/2007]) | 0 | 762 | 0 |
| other | Lymphatic disorder | Blood and lymphatic system disorders | Arm I (CA for 4 Courses) | 0 | 1,110 | 0 |
| other | Lymphatic disorder | Blood and lymphatic system disorders | Arm II (CA for 6 Courses [Closed to Accrual 12/15/2007]) | 0 | 765 | 0 |
| other | Lymphatic disorder | Blood and lymphatic system disorders | Arm III (Paclitaxel for 4 Courses) | 0 | 1,118 | 0 |
| other | Lymphatic disorder | Blood and lymphatic system disorders | Arm IV (Paclitaxel for 6 Courses [Closed 12/15/2007]) | 2 | 762 | 2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00041119/events